Biology and treatment of familial hemophagocytic lymphohistiocytosis: Importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis

被引:56
作者
Henter, JI [1 ]
机构
[1] Karolinska Hosp, Childhood Canc Res Unit Q6 05, Dept Pediat Hematol & Oncol, Astrid Lindgren Childrens Hosp, S-17176 Stockholm, Sweden
[2] Univ British Columbia, BCs Childrens Hosp, Dept Pediat, Vancouver, BC V5Z 1M9, Canada
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 2002年 / 38卷 / 05期
关键词
familial hemophagocytic lymphohistiocytosis; perforin; apoptosis; cytotoxicity; natural killer cell;
D O I
10.1002/mpo.1340
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Familial hemolphagocytic lymphohistiocytosis (FHL) is, without treatment, an invariably fatal disease of infancy and early childhood characterized by fever, hepatosplenomegaly, pancytopenia, and a widespread accumulation of T-lymphocytes and macrophages. During recent years, the diagnosis and the survival as well as the understanding of the disease have improved dramatically. Recent studies suggest that FHL is caused by impaired lymphocyte-mediated cytotoxicity and defective triggering of apoptosis, and that the symptoms are mediated by a pro-inflammatory hypercytokinemia. Moreover, specific genetic alterations, mutations in the perforin gene, have been revealed in FHL patients. Perforin, which normally is secreted from cytotoxic T-lymphocytes and natural killer (NK) cells upon conjugation between effector and target cells, is able to insert into the membrane of the target cell. It there polymerizes to form a cell death-inducing pore through which toxic granzymes may enter the cell and trigger apoptosis. The establishment of perforin deficiency as a cause of the rapidly fatal disease FHL has demonstrated the essential role of perforin in human immune homeostasis. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:305 / 309
页数:5
相关论文
共 30 条
  • [1] AMBRUSO DR, 1980, CANCER, V45, P2516, DOI 10.1002/1097-0142(19800515)45:10<2516::AID-CNCR2820451008>3.0.CO
  • [2] 2-V
  • [3] NATURAL CYTO-TOXICITY IMPAIRMENT IN FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
    ARICO, M
    NESPOLI, L
    MACCARIO, R
    MONTAGNA, D
    BONETTI, F
    CASELLI, D
    BURGIO, GR
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1988, 63 (03) : 292 - 296
  • [4] Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
    Cavazzana-Calvo, M
    Hacein-Bey, S
    Basile, CD
    Gross, F
    Yvon, E
    Nusbaum, P
    Selz, F
    Hue, C
    Certain, S
    Casanova, JL
    Bousso, P
    Le Deist, F
    Fischer, A
    [J]. SCIENCE, 2000, 288 (5466) : 669 - 672
  • [5] Linkage of familial hemophagocytic lymphohistiocytosis to 10q21-22 and evidence for heterogeneity
    Dufourcq-Lagelouse, R
    Jabado, N
    Le Deist, F
    Stéphan, JL
    Souillet, G
    Bruin, M
    Vilmer, E
    Schneider, M
    Janka, G
    Fischer, A
    Basile, GD
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (01) : 172 - 179
  • [6] Improved outcome in haemophagocytic lymphohistiocytosis after bone marrow transplantation from related and unrelated donors:: a single-centre experience of 12 patients
    Dürken, M
    Horstmann, M
    Bieling, P
    Erttmann, R
    Kabisch, H
    Löliger, C
    Schneider, EM
    Hellwege, HH
    Krüger, W
    Kröger, N
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (04) : 1052 - 1058
  • [7] Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis
    Egeler, RM
    Shapiro, R
    Loechelt, B
    Filipovich, A
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1996, 18 (04) : 340 - 345
  • [8] Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis
    Ericson, KG
    Fadeel, B
    Nilsson-Ardnor, S
    Söderhäll, C
    Samuelsson, A
    Janka, G
    Schneider, M
    Gürgey, A
    Yalman, N
    Révész, T
    Egeler, RM
    Jahnukainen, K
    Storm-Mathiesen, I
    Haraldsson, A
    Poole, J
    de Saint Basile, G
    Nordenskjöld, M
    Henter, JI
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2001, 68 (03) : 590 - 597
  • [9] Induction of apoptosis and caspase activation in cells obtained from familial haemophagocytic lymphohistiocytosis patients
    Fadeel, B
    Orrenius, S
    Henter, JI
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) : 406 - 415
  • [10] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ERYTHROPHAGOCYTIC LYMPHOHISTIOCYTOSIS
    FISCHER, A
    CERFBENSUSSAN, N
    BLANCHE, S
    LEDEIST, F
    BREMARDOURY, C
    LEVERGER, G
    SCHAISON, G
    DURANDY, A
    GRISCELLI, C
    [J]. JOURNAL OF PEDIATRICS, 1986, 108 (02) : 267 - 270